Silene Biotech (acquired by NanoSurface Bio)

🗓 Founded 2015👥 2 employees💰 Last funded Mar 2018
Biotechnology🌐 silenebiotech.com
Website LinkedIn
Cell preservation today for the personalized therapies and diagnostics of tomorrow. Silene Biotech offers consumers affordable, accessible personalized cell preservation using protocols and standards meeting current Good Manufacturing Processes as established by the FDA.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Silene Biotech (acquired by NanoSurface Bio)?
Silene Biotech (acquired by NanoSurface Bio) has 1 investors on record on gritt.io, 1 mid-stage.
When did Silene Biotech (acquired by NanoSurface Bio) last raise funding?
The most recent investment in Silene Biotech (acquired by NanoSurface Bio) recorded on gritt.io was in March 2018.
When was Silene Biotech (acquired by NanoSurface Bio) founded?
Silene Biotech (acquired by NanoSurface Bio) was founded in 2015.
What industry is Silene Biotech (acquired by NanoSurface Bio) in?
Silene Biotech (acquired by NanoSurface Bio) operates in Biotechnology. Find similar Biotechnology investors on gritt.io.